dabigatran etexilate low dose

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyHeart Valve DiseasesHeart Valve ProsthesisRenal InsufficiencyThromboembolism

Phase 1

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

CompletedNCT02171455

Boehringer IngelheimHealthy

Start: 2006-01-31Updated: 2014-06-24

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

CompletedNCT02182024

Boehringer IngelheimRenal Insufficiency

Start: 2005-04-30Updated: 2014-07-18

Phase 2

Dabigatran Etexilate in Patients With Mechanical Heart Valves

TerminatedNCT01452347

Boehringer IngelheimHeart Valve Diseases

Start: 2011-10-31End: 2013-06-30Updated: 2014-08-06

Follow on Study From RE-ALIGN

TerminatedNCT01505881

Boehringer IngelheimHeart Valve Prosthesis, Thromboembolism

Start: 2011-12-31End: 2013-06-30Updated: 2014-07-11

Related Papers

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

New England Journal of Medicine2013-09-011480 citations